Stocks in Focus

Shares Soar for Second Straight Day on Expectations of Renewable Energy Business Restructuring… SK E&T Up 15% [Featured Stock]

[Edaily Reporter Kwon Oh-seok] #SK E-Tronics’ stock price has surged for two consecutive days. Buying momentum continues amid media reports that SK Group plans to sell part of its renewable energy business to a global investment firm and establish a joint venture.

According to MP Doctor on the 11th, SK E&T was trading at 51,000 won as of 9:10 a.m., up 14.99% from the previous trading day.
This is interpreted as a result of reports that the SK Group is set to sign an agreement to sell key renewable energy businesses within the group to the global investment firm KKR (Kohlberg Kravis Roberts), which has stimulated investor sentiment. According to a media report on the 9th, SK Group has decided to sign an agreement to sell businesses worth approximately 1.8 trillion won to KKR, including SK Discovery’s roughly 30% controlling stake in SK E-Tronics, SK Innovation E&S’s renewable energy business, and SK Eco Plant’s renewable energy business.
Consequently, SK E-Tronics’ stock price closed at the daily price limit again yesterday (the 10th), breaking through the 50,000 won mark.

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02